Isosulfan blue
- Generic Name
- Isosulfan blue
- Brand Names
- Lymphazurin
- Drug Type
- Small Molecule
- Chemical Formula
- C27H33N2O6S2
- CAS Number
- 748080-29-7
- Unique Ingredient Identifier
- NS6Q291771
- Indication
Isosulfan Blue is a synthetic visual lymphatic imaging agent. Isosulfan blue upon subcutaneous administration, delineates the lymphatic vessels draining the region of injection. It is an adjunct to lymphography in: primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neo...
- Associated Conditions
- Chylothorax, Chylous Ascites, Chyluria, Secondary and unspecified malignant neoplasm of lymph nodes, Lymph node response to therapeutic modalities, Lymphedema of the extremities
- Associated Therapies
- -
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection
- First Posted Date
- 2019-04-25
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 534
- Registration Number
- NCT03927027
- Locations
- ๐บ๐ธ
Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
๐บ๐ธThomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
๐บ๐ธGeisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States
Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
- Conditions
- Interventions
- First Posted Date
- 2013-09-11
- Last Posted Date
- 2020-08-27
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 58
- Registration Number
- NCT01939028
- Locations
- ๐บ๐ธ
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Lymph Node Mapping in Patients With Endometrial Cancer
- Conditions
- Interventions
- First Posted Date
- 2013-03-26
- Last Posted Date
- 2023-03-22
- Target Recruit Count
- 204
- Registration Number
- NCT01818739
- Locations
- ๐บ๐ธ
Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, United States
๐บ๐ธArthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States
Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2013-01-18
- Last Posted Date
- 2017-12-11
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 23
- Registration Number
- NCT01771666
- Locations
- ๐บ๐ธ
Stanford University, School of Medicine, Stanford, California, United States
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
- Conditions
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Saint John's Cancer Institute
- Target Recruit Count
- 225
- Registration Number
- NCT00625625
Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer
- First Posted Date
- 2007-03-22
- Last Posted Date
- 2017-02-07
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 39
- Registration Number
- NCT00450723
- Locations
- ๐บ๐ธ
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States
Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2007-02-22
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 74
- Registration Number
- NCT00438477
- Locations
- ๐บ๐ธ
M. D. Anderson Cancer Center at University of Texas, Houston, Texas, United States
Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer
- Conditions
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2013-02-05
- Lead Sponsor
- Roswell Park Cancer Institute
- Registration Number
- NCT00003186
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 102
- Registration Number
- NCT00070317
- Locations
- ๐บ๐ธ
Gynecologic Oncology Group, Philadelphia, Pennsylvania, United States
Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-03-11
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00012168
- Locations
- ๐บ๐ธ
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.